Cargando…
MGMT and Whole-Genome DNA Methylation Impacts on Diagnosis, Prognosis and Therapy of Glioblastoma Multiforme
Epigenetic changes in DNA methylation contribute to the development of many diseases, including cancer. In glioblastoma multiforme, the most prevalent primary brain cancer and an incurable tumor with a median survival time of 15 months, a single epigenetic modification, the methylation of the O(6)-M...
Autores principales: | Della Monica, Rosa, Cuomo, Mariella, Buonaiuto, Michela, Costabile, Davide, Franca, Raduan Ahmed, Del Basso De Caro, Marialaura, Catapano, Giuseppe, Chiariotti, Lorenzo, Visconti, Roberta |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9266959/ https://www.ncbi.nlm.nih.gov/pubmed/35806153 http://dx.doi.org/10.3390/ijms23137148 |
Ejemplares similares
-
A Rare Adult Primary Intracranial Sarcoma, DICER1-Mutant Identified by Epigenomic Profiling: A Case Report
por: Marinelli, Alfredo, et al.
Publicado: (2023) -
Evaluation of MGMT Gene Methylation in Neuroendocrine Neoplasms
por: Della Monica, Rosa, et al.
Publicado: (2022) -
Looking Beyond the Glioblastoma Mask: Is Genomics the Right Path?
por: Montella, Liliana, et al.
Publicado: (2022) -
Targeted inhibition of the methyltransferase SETD8 synergizes with the Wee1 inhibitor adavosertib in restraining glioblastoma growth
por: Della Monica, Rosa, et al.
Publicado: (2023) -
Epigenetic remodelling of Fxyd1 promoters in developing heart and brain tissues
por: Cuomo, Mariella, et al.
Publicado: (2022)